Tech Company Financing Transactions
CollimateHealth Funding Round
On 6/15/2026, CollimateHealth secured $6.8 million in Seed funding from Caesar Ventures, High-Tech Gründerfonds and Positron Venture.
Transaction Overview
Company Name
Announced On
6/15/2026
Transaction Type
Venture Equity
Amount
$6,800,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Lilly-Reich-Str. 8
Munich, 80807
Germany
Munich, 80807
Germany
Phone
Undisclosed
Website
Email Address
Overview
CollimateHealth develops a clinically scalable microbeam radiation technology designed to reshape the way cancer is treated. While conventional radiation oncology typically relies on broad and lower-dose beams that cause significant side effects, microbeam radiation delivers an array of extremely narrow, micrometer-scale beams at substantially higher dose.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hans Heÿn
Chief Scientific Officer
Stefan Bartzsch
Chief Technical Officer
Johanna Winter
Browse more venture capital transactions:
Prev: 6/15/2026: Copperlane venture capital transaction
Next: 6/15/2026: Orbio AI venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs